DUCTAL CARCINOMA IN SITU
Clinical trials for DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to stop early breast changes before they become cancer
Disease control Not yet recruitingThis early-phase study tests a drug called CAN1012, which is injected directly into areas of the breast with pre-cancerous changes (DCIS or LCIS). The main goal is to see if the drug is safe and does not delay needed surgery. About 24 adults with a single breast lesion between 1 …
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New scanner could slash repeat breast cancer surgeries by half
Diagnosis Not yet recruitingThis study tests a special scanner that lets surgeons check, in real time during surgery, whether they removed all the cancer from the breast. It is for women with certain high-risk breast cancer types. If the scanner shows leftover cancer, the surgeon can remove more tissue righ…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Hôpital du Valais • Aim: Diagnosis
Last updated May 26, 2026 06:09 UTC
-
New MRI scanner aims to sharpen breast tumor measurements
Diagnosis Not yet recruitingThis study tests a new type of MRI scanner, called Field-Cycling Imaging (FCI), to see if it can more accurately measure the size of breast tumors in people with ductal carcinoma in situ (DCIS). About 12 participants will have both a standard MRI and an FCI scan before their surg…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: University of Aberdeen • Aim: Diagnosis
Last updated May 26, 2026 06:07 UTC